In the battle against COVID-19, various companies have been working on developing tests with dramatically reduced turnaround times, while others are working frenetically on developing potential vaccines. When it comes to his top stock for the fight against COVID-19, however, the author of today’s article has a “slightly different” pick: “a classic picks-and-shovel play…which makes software that lets drug companies simulate tests of their products in the virtual world before undergoing human or animal testing. This is a big cost saver for drug companies.” For more, CLICK HERE.
“I don’t understand how to make money as a bear,” laments the author of today’s article, who’s having his first experience being an investment bear in an unprecedented market situation. So what’s the most attractive option for making money as a bear: Shorting stocks? Converting to cash? Buying puts? For the author’s assessment of these strategies – and why he concludes that the best approach may be to “survive as a bear, then profit as a bull” – CLICK HERE.
People need to change the way they think about buying assets during a panic, argues the author of today’s article, who notes that “Despite the seemingly obvious upside to buying during the current panic, many investors (even those sitting on lots of cash) are afraid to do so. This seems to be partially an issue with uncertainty around a further decline, but it also seems to be a framing issue as well.” How can investors go about “reframing the upside”? CLICK HERE.
“No move is better than a bad move.” This caution regarding how investors respond to the market turmoil brought on by the coronavirus outbreak comes from Jeffrey Sherman, deputy chief investment officer at DoubleLine. In today’s article, Sherman offers up his thoughts on the biggest risks with respect to the virus, where investors should be careful in this environment, the best investment ideas right now, and more. CLICK HERE.
Tesla’s stock, which has more than quadrupled since last summer, would certainly seem to be in a bubble – and now one model is indicating that, based on the magnitude of Tesla’s price run-up over the trailing two years, there is a more than 80% chance that bubble will burst. For more – including why the odds of a Tesla stock crash may be even worse than this model suggests – CLICK HERE.
While Amazon is the king of online retail, the author of today’s article points to an Achilles heel that threatens its crown – and that has Walmart nipping at the online retail behemoth’s heels. What is Amazon’s Achilles heel, what’s Walmart’s master plan to take advantage of it and charge ahead of its rival, and is buying Walmart stock like buying Amazon stock but at a 73% discount? CLICK HERE.
More than 10 years into this bull market, Buy and Outperform analyst ratings generally come with implied upside potential of 8% to 10%. However, the author of today’s article notes that “One area of the market that can see much greater upside opportunities, which also implies a greater risk, is the biotech and emerging pharmaceutical stocks” – and he proceeds to highlight 20 biotech and pharma stocks that have seen analyst calls since January 1st that suggest much larger upside potential. For more, CLICK HERE.
Investors may be wary of health care stocks heading into an election year where the future of health care in the U.S. will be hotly debated – and drug companies are likely to be the targets of heated rhetoric on both sides. However, Goldman Sachs believes that any changes will be “evolutionary rather than revolutionary” – and its strategists have identified three health care stocks set to outperform next year. For these three stocks, CLICK HERE.
Many articles and books have been written – and movies made – telling stories from the 2008 financial crisis – from those who lost everything to those who made a fortune. However, the author of today’s article states that “there’s an incredible story from 2008 that few people know.” He proceeds to tell that story — about how investors could have made a killing by buying one of the world’s biggest financial companies during the financial crisis — and highlights its lesson for investors about a type of stock that “can deliver huge returns during any kind of market.” CLICK HERE.
Halloween is over and assorted monster costumes have been put away – but there is still monster growth to be had in certain stocks! Today’s article highlights three stocks “with strong monster growth narratives” – each of which has recently reported impressive earnings numbers and had their price targets increased by some of Wall Street’s top-performing analysts as a result. For these three “monster growth” stocks – all of which have “Strong Buy” consensus ratings and upside potential above 20% – CLICK HERE.